MarginsXMarginsX
Home › Markets › Health Care › RVP

Retractable Technologies Inc. (RVP)

RVP trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.5600
+0.02% on the day
Market cap
$16.8M
Nano cap
Revenue · 2025
$38.3M
+15.8% on 2024
Net income · 2025
-$12.6M
-32.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/946563/000110465926036053/0001104659-26-036053-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerRVP on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2001
SEC CIK0000946563
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inTX

Financials · 2025

LineValue
Revenue$38.3M
Net income-$12.6M
Operating income-$21.2M
Net margin-32.8%
Operating margin-55.3%
Revenue growth+15.8%
Cash$2.6M
Total assets$142.6M
P/E (computed)Net income was not positive
P/S (computed)0.4×

Warning signs

Cash runway
6.4 months
$2.6M cash at June 30, 2026
Share count, 1 year
0.0%
2025-08-01 to 2026-08-01 · 0.0% over 3 years
Going-concern doubt
No
10-Q filed August 14, 2026
Insider net buying, 12 months
$139K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-14
Cash and burn$2.6M cash; operating cash flow -$1.2M a quarter.Report 2026-06-30
Shares outstanding29,937,159 (2026-08-01); 29,937,159 a year earlier; 29,937,159 three years earlier.Cover page 2026-08-01
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBaker Tilly US, LLP, Dallas, Texas, United States; changed auditors 1 time in 24 months8-K 4.01 2025-06-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $139K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$7.2M$2.8M-$1.7M$2.6M$379K$33.9M10-Q 2026-08-14
Q1 2026
2026-03-31
$7.2M-$4.2M-$1.4M$2.8M$372K$37.1M10-Q 2026-05-15
Q4 2025
2025-12-31
$9.4M-$2.3M-$597K$2.6M$896K$38.3M10-K 2026-03-27
Q3 2025
2025-09-30
$10.1M$371K-$1.3M$3.4M$983K$37.9M10-Q 2025-11-14
Q2 2025
2025-06-30
$10.4M-$87K-$3.7M$3.0M$1.1M$38.2M10-Q 2026-08-14
Q1 2025
2025-03-31
$8.3M-$10.5M-$1.5M$3.4M$1.2M$33.7M10-Q 2026-05-15
Q4 2024
2024-12-31
$9.1M$3.8M-$1.1M$4.2M$1.2M$33.0M10-K 2026-03-27
Q3 2024
2024-09-30
$10.3M-$1.9M-$5.7M$3.9M$1.3M$38.3M10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report10-K2026-03-27
Latest quarterly / interim10-Q2026-11-16
Latest current report
FORM 8-K
8-K2026-11-16
Latest proxyDEFA14A2026-03-27

Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.8%
1 month-8.2%
3 months-17.6%
Year to date-27.3%
1 year-30.9%
From 52-week high-32.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
CVRXCVRx Inc.$0.6130+0.92%$17.5M
PMIPicard Medical Inc.$7.24+0.14%$17.8M
SNWVSANUWAVE Health Inc.$1.81-0.55%$15.6M
MODDModular Medical Inc.$1.91-3.05%$18.1M
CTSOCytosorbents Corporation$4.85-0.41%$15.3M
PAVMPAVmed Inc.$1.75+7.36%$14.0M
GUTSFractyl Health Inc.$0.9918+9.76%$13.2M
DRIODarioHealth Corp.$1.15-8.73%$13.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier